CV Editor

Dr. Franklin Geovany Mora Bravo, MD, Nph, MsC

 

Editor REV SEN

Affiliation: Pafram Unidad de Hemodiafiltración, Red Complementaria de Salud de Morona Santiago, Ecuador.

ORCID: https://orcid.org/0000-0002-5978-3420

RESEARCHER ID: B-9061-2017

SCOPUS ID: 25937452400

Scholar Google: Indice h: 10

Academic titles:

Doctor of Medicine and Surgery from the University of Cuenca, Ecuador (1998).

Specialist in Internal Medicine from the National University of Loja, Ecuador (2003).

Specialist in Nephrology from the National Autonomous University of Mexico, Mexico (2008).

Diploma in Higher Education by competencies from the University of Azuay, Cuenca (2013).

Master's degree in Health Research from the University of Cuenca, Ecuador (2017).

 

Current Job:

Medical Director of the Pafram Hemodiafiltration Unit, Complementary Health Network of Morona Santiago.

Editor of the Journal of the Ecuadorian Society of Nephrology, Dialysis and Transplantation, REV SEN.

 

Positions and distinctions:

Coordinator of the Kidney Transplant program of the José Carrasco Arteaga Hospital of the Ecuadorian Institute of Social Security in Cuenca, Ecuador, Period 2010-2018.

President of the Ecuadorian Society of Organ and Tissue Transplantation -SETOT period 2010-2014.

Professor of the Chair of Nephrology at the School of Medicine, Faculty of Medical Sciences, University of Cuenca, period 2008-2019.

 

Editorial Experience:

* Editor of the Medical Journal of the Hospital "José Carrasco Arteaga" 2011–2018. Ecuadorian Institute of Social Security, Cuenca, Ecuador.

* Director of the Journal of the Faculty of Medical Sciences of the University of Cuenca Period January-October 2020, Cuenca, Ecuador.

* Editorial Advisor of the Ecuadorian Journal of Pediatrics - of the Ecuadorian Society of Pediatrics-Quito nucleus. Period 2020-2022.

*Editor and Founder of the Journal of the Ecuadorian Society of Nephrology Period February 2022- to the present.

 

Publications indexed in MEDLINE:

https://pubmed/mora-bravo

 

1: Mora-Bravo F, Muñoz J. Impaired Reconversion of Bone Marrow in Nuclear
Magnetic Resonance in Patients with Chronic Renal Disease. Curr Med Imaging.
2021;17(10):1256-1261. doi: 10.2174/1573405616999201118140832. PMID: 33213332.

2: Mora-Bravo FG, Mariscal A, Herrera-Felix JP, Magaña S, De-La-Cruz G, Flores
N, Rosales L, Franco M, Pérez-Grovas H. Arterial line pressure control enhanced
extracorporeal blood flow prescription in hemodialysis patients. BMC Nephrol.
2008 Nov 24;9:15. doi: 10.1186/1471-2369-9-15. PMID: 19025625; PMCID:
PMC2613872.

3: Alemán-Iñiguez JM, Mora-Bravo F, Bravo-Aguilar C. Rare brown tumor location
in chronic renal failure. Nefrologia. 2016 Sep-Oct;36(5):560-562. English,
Spanish. doi: 10.1016/j.nefro.2016.03.017. Epub 2016 Jun 11. PMID: 27298268.

4: Rivera-González SC, Pérez-Grovas H, Madero M, Mora-Bravo F, Saavedra N,
López-Rodriguez J, Lerma C. Identification of impeding factors for dry weight
achievement in end-stage renal disease after appropriate kidney graft function.
Artif Organs. 2014 Feb;38(2):113-20. doi: 10.1111/aor.12133. Epub 2013 Jul 25.
PMID: 23889479.

5: Sánchez Vega JF, Murillo Bacilio MDR, Vintimilla Condoy AS, Palta González
AM, Crespo Astudillo JA, Mora-Bravo FG. Predictive equation of metastasis in
patients with malignant ovarian epithelial tumors with the Ca-125 marker. BMC
Cancer. 2018 May 24;18(1):587. doi: 10.1186/s12885-018-4499-y. PMID: 29793429;
PMCID: PMC5968491.

6: Mora-Bravo FG, Torres PTM, Campoverde NR, Carcelen GLB, Mancheno JCS, Tipanta
ÁCS, Perez-Grovas H, Abarca WPR. Blood pressure control with active
ultrafiltration measures and without antihypertensives is essential for survival
in hemodiafiltration and hemodialysis programs for patients with CKD: a
prospective observational study. BMC Nephrol. 2025 Jan 17;26(1):30. doi:
10.1186/s12882-025-03948-0. PMID: 39825259; PMCID: PMC11742504.

7: Quinchuela J, Tamayo G, Benavides N, Mora-Bravo F. A Multicenter Propensity
Score Matching Study of Homologous Convective Volume (HCV): A New Comprehensive
Parameter for Dialysis Dose That Improves Survival. Cureus. 2025 Nov
5;17(11):e96157. doi: 10.7759/cureus.96157. PMID: 41200257; PMCID: PMC12588620.

8: Mora-Bravo FG, De-La-Cruz G, Rivera S, Ramírez AM, Raimann JG, Pérez-Grovas
H. Association of intradialytic hypotension and convective volume in
hemodiafiltration: results from a retrospective cohort study. BMC Nephrol. 2012
Sep 10;13:106. doi: 10.1186/1471-2369-13-106. PMID: 22963170; PMCID: PMC3575237.